FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per V...
FDA Drug Recall #D-0436-2024 — Class II — February 29, 2024
Recall Summary
| Recall Number | D-0436-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 29, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | SSM Health Care St. Louis DBA SSM St. Clare Health Center |
| Location | Fenton, MO |
| Product Type | Drugs |
| Quantity | 140 vials |
Product Description
FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per Vial, Intravenous, Rx Only, Hospital/Office Use Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-9010-1
Reason for Recall
Lack of Assurance of Sterility: Firm did not perform process validation.
Distribution Pattern
MO
Lot / Code Information
Lot: 20231031-0C91D9, Exo 29-Feb-2024.
Other Recalls from SSM Health Care St. Louis DBA SSM St....
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0435-2024 | Class II | Phenylephrine HCl, 1000 mcg/10 mL, 10 mL Total ... | Feb 29, 2024 |
| D-0776-2023 | Class II | HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridg... | May 9, 2023 |
| D-0007-2022 | Class II | Potassium Chloride 40 mEq in 0.9% Sodium Chlori... | Sep 22, 2021 |
| D-0143-2018 | Class II | Oxytocin 30 units in 0.9% Sodium Chloride 500 m... | Aug 10, 2017 |
| D-0144-2018 | Class II | Phenylephrine 1000 mcg in 0.9% Sodium Chloride ... | Aug 10, 2017 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.